Addex Therapeutics Ltd: management transactions · Switzerland · SIX SER SIX:addex-therapeutics-ltd CH0029850754 CH CH · SIX SER Mcap 6M€
Browse the full directors' dealings record of Addex Therapeutics Ltd, a publicly traded company based in Switzerland. Shares trade on CH CH, under the authority of SIX SER. Market capitalisation: €5.6m. The latest transaction was reported on 27 November 2023 — Purchase. Among the most active insiders: Anonymous (Executive member of the board of directors / member of senior management). Every trade is accessible without an account.
Financial data FY ended December 2024 · cache
Income statement
Revenue 404 k€
Net income 7.1 M€ 1746.0% margin
Balance sheet & cash
Market cap 5.6 M€
Total debt 42 k€
Free Cash Flow −5.4 M€
Last declaration on 27 November 2023
Declarations 9 total
Executives ● Purchase37 SIX
€312,181 7,008,033 shares @ €0.0445 5.55% mcap 73.8% of flow CH0029850754⌘
SIX:T1NBR00080 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270) Executives ● Purchase27 SIX
€55,693 1,250,224 shares @ €0.0445 0.99% mcap 13.2% of flow CH0029850754⌘
SIX:T1NBR000A6 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270) Executives ● Purchase36 SIX
€46,469 1,043,153 shares @ €0.0445 0.83% mcap 58.2% of flow CH0029850754⌘
SIX:T1NBR000C2 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270) Executives ● Purchase31 SIX
€25,301 567,969 shares @ €0.0445 0.45% mcap 31.7% of flow CH0029850754⌘
SIX:T1NBR000D0 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270) Executives ● Purchase21 SIX
€5,684 127,594 shares @ €0.0445 0.10% mcap 1.3% of flow CH0029850754⌘
SIX:T1NBR000B4 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270) Executives ● Purchase25 SIX
€4,068 91,323 shares @ €0.0445 0.072% mcap 5.1% of flow CH0029850754⌘
SIX:T1NBR000F5 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270) Executives ● Purchase25 SIX
€4,068 91,323 shares @ €0.0445 0.072% mcap 5.1% of flow CH0029850754⌘
SIX:T1NBR000E8 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270) Executives ● Purchase27 SIX
€47,084 1,056,966 shares @ €0.0445 0.84% mcap 11.1% of flow CH0029850754⌘
SIX:T1NBR00098 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270) Executives ● Purchase18 SIX
€2,227 50,000 shares @ €0.0445 0.040% mcap 0.5% of flow CH0029850754⌘
SIX:T1NBR000G3 · 27 Nov 2023
Ideal exit: 23 Aug 2024 (T+270)